Emerging NASH Treatments
Hear Philip N. Newsome, PhD, FRCPE, discuss the agents in late-phase clinical trials and their potential use in the treatment of NASH and fibrosis, including those in phase III such as: Obeticholic acid Cenicriviroc Resmetirom Aramchol Download the slides from this podcast at:https://bit.ly/3eJYKvW See more NASH topics at: https://bit.ly/3ezkBq6